Lessee, Operating Lease, Liability, to be Paid, Year Three of INTEGRATED BIOPHARMA INC from 30 Sep 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
INTEGRATED BIOPHARMA INC quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 30 Sep 2018 to 31 Dec 2024.
  • INTEGRATED BIOPHARMA INC Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2024 was $64,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)

INTEGRATED BIOPHARMA INC Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $64,000 31 Dec 2024 10-Q 13 Feb 2025 2025 Q2
Q3 2024 $64,000 30 Sep 2024 10-Q 13 Nov 2024 2025 Q1
Q2 2021 $572,000 30 Jun 2021 10-K 02 Sep 2021 2021 FY
Q4 2018 $587,000 31 Dec 2018 10-Q 13 Feb 2019 2019 Q2
Q3 2018 $586,000 30 Sep 2018 10-Q 09 Nov 2018 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.